Am. J. Respir. Crit. Care Med., Volume 156, Number 4, October 1997, S78-S81

Cytokine Manipulation in Animal Models of Asthma

ROMAIN A. PAUWELS, GUY J. BRUSSELLE, and JOHAN C. KIPS

Department of Respiratory Diseases, University Hospital, Ghent, Belgium

We have developed in C57 Black 6 mice an in vivo model of allergic airway inflammation characterized by the presence of IgE antibodies to an inhaled antigen, peribronchial infiltrates with an increased number of eosinophils, and an increased airway responsiveness to nonantigenic bronchoconstrictor stimuli. In this animal model we have investigated the role of different cytokines in the development of IgE antibodies to inhaled antigen, eosinophilic airway inflammation, and airway hyperresponsiveness. The studies were performed by using knockout mice or by exogenous administration of cytokines or cytokine antagonists. Interleukin-4 (IL-4) knockout mice were unable to develop an allergic eosinophilic airway infiltration and did not produce specific IgE antibodies. Chronic aerosol exposure to antigen also did not induce an increase in airway responsiveness. In studies of wild-type mice, pretreatment with the combination of anti-IL5 and anti-IL-5 receptor antibodies, given in an attempt to fully inhibit the effect of endogenously released IL-5, caused a pronounced inhibition of the antigen-induced airway eosinophilia but did not prevent the increase in airway responsiveness. Treatment with IL-12 during the active immunization prevented airway eosinophilia, production of specific IgE antibodies, and the antigen-induced increase in airway responsiveness. In contrast, administration of IL-12 to actively immunized mice during the aerosol exposure abolished airway eosinophilia and airway hyperresponsiveness without affecting the production of specific IgE. Pauwels RA, Brusselle GJ, Kips JC. Cytokine manipulation in animal models of asthma.

This article has been cited by other articles:

				M. Humbert Biologics in severe difficult-to-treat asthma: find the right niche! Eur. Respir. Rev., June 1, 2009; 18(112): 51 - 53. [Full Text] [PDF]

				F. M. Arantes-Costa, F. D.T.Q.S. Lopes, A. C. Toledo, P. A. Magliarelli-Filho, H. T. Moriya, R. Carvalho-Oliveira, T. Mauad, P. H. N. Saldiva, and M. A. Martins Effects of Residual Oil Fly Ash (ROFA) in Mice with Chronic Allergic Pulmonary Inflammation Toxicol Pathol, July 1, 2008; 36(5): 680 - 686. [Abstract] [Full Text] [PDF]

				J. M. Matheson, V. J. Johnson, and M. I. Luster Immune Mediators in a Murine Model for Occupational Asthma: Studies with Toluene Diisocyanate Toxicol. Sci., March 1, 2005; 84(1): 99 - 109. [Abstract] [Full Text] [PDF]

				G. Pynaert, P. Rottiers, A. Haegeman, S. Sehra, T. Van Belle, J. Korf, and J. Grooten Antigen Presentation by Local Macrophages Promotes Nonallergic Airway Responses in Sensitized Mice Am. J. Respir. Cell Mol. Biol., November 1, 2003; 29(5): 634 - 641. [Abstract] [Full Text]

				J. M. Matheson, R. Lemus, R. W. Lange, M. H. Karol, and M. I. Luster Role of Tumor Necrosis Factor in Toluene Diisocyanate Asthma Am. J. Respir. Cell Mol. Biol., October 1, 2002; 27(4): 396 - 405. [Abstract] [Full Text] [PDF]

				A. M. Khan, O. Elidemir, C. E. Epstein, K. P. Lally, H. Xue, M. Blackburn, G. L. Larsen, and G. N. Colasurdo Meconium aspiration produces airway hyperresponsiveness and eosinophilic inflammation in a murine model Am J Physiol Lung Cell Mol Physiol, October 1, 2002; 283(4): L785 - L790. [Abstract] [Full Text] [PDF]

				R. K. Kumar and P. S. Foster Modeling Allergic Asthma in Mice: Pitfalls and Opportunities Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 267 - 272. [Abstract] [Full Text]

				B. D. Medoff, A. Sauty, A. M. Tager, J. A. Maclean, R. N. Smith, A. Mathew, J. H. Dufour, and A. D. Luster IFN-{gamma}-Inducible Protein 10 (CXCL10) Contributes to Airway Hyperreactivity and Airway Inflammation in a Mouse Model of Asthma J. Immunol., May 15, 2002; 168(10): 5278 - 5286. [Abstract] [Full Text] [PDF]

				S. Kawasaki, H. Takizawa, H. Yoneyama, T. Nakayama, R. Fujisawa, M. Izumizaki, T. Imai, O. Yoshie, I. Homma, K. Yamamoto, et al. Intervention of Thymus and Activation-Regulated Chemokine Attenuates the Development of Allergic Airway Inflammation and Hyperresponsiveness in Mice J. Immunol., February 1, 2001; 166(3): 2055 - 2062. [Abstract] [Full Text] [PDF]

				M. L. KAPSENBERG, C. M. U. HILKENS, T. C. M. T. van der POUW KRAAN, E. A. WIERENGA, and P. KALINSKI Atopic Allergy: A Failure of Antigen-Presenting Cells to Properly Polarize Helper T Cells? Am. J. Respir. Crit. Care Med., September 1, 2000; 162(3): S76 - 80. [Full Text] [PDF]

				K. HAMADA, C.-A. GOLDSMITH, A. GOLDMAN, and L. KOBZIK Resistance of Very Young Mice to Inhaled Allergen Sensitization Is Overcome by Coexposure to an Air-Pollutant Aerosol Am. J. Respir. Crit. Care Med., April 1, 2000; 161(4): 1285 - 1293. [Abstract] [Full Text]

				M. R. van Scott, J. P. Justice, J. F. Bradfield, E. Enright, A. Sigounas, and S. Sur IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice Am J Physiol Lung Cell Mol Physiol, April 1, 2000; 278(4): L667 - L674. [Abstract] [Full Text] [PDF]

				M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF]

				J. M. DRAZEN and E. K. SILVERMAN Genetics of Asthma . Conference Summary Am. J. Respir. Crit. Care Med., October 1, 1997; 156(4): S69 - S71. [Full Text] [PDF]